Meridian Bioscience (NASDAQ:VIVO) announced on Wednesday that the company’s wholly-owned subsidiary, Magellan Diagnostics, expanded the voluntary recall of LeadCare test kits.
The U.S. Food and Drug Administration said on Monday it issued a warning letter to Meridian Bioscience Inc’s unit for several federal law violations after inspecting its facility that makes lead-testing devices.